FDA Approved: SULFASALAZINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for sulfasalazine from Teva Pharmaceuticals USA, updating the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis
• Ulcerative Colitis

Drugs mentioned

• Sulfasalazine (Sulfasalazine)

Snippet

SUPPL AP for SULFASALAZINE (SULFASALAZINE)